Biologics Market Research Reports & Industry Analysis
The biologics industry includes a wide range of therapeutic products derived from biological sources and is a fundamental part of modern healthcare. Biologics play a vital role in advancing treatments for various diseases and conditions. MarketResearch.com offers a comprehensive collection of biologics industry reports to provide valuable insights into the most recent market trends, challenges, and opportunities to watch.
Biologics Market Growth Forecasts
- Access detailed information about a variety of distinct market segments, such as recombinant proteins, vaccines, and more.
- Obtain biologics market sizing and growth projections to gain a clear understanding of market potential and outlook.
- Analyze leading players and competitor strategies to stay one step ahead in a competitive market.
The MarketResearch.com Advantage
MakretResearch.com has been a trailblazer in the field of market research for more than two decades and continues to serve many of the largest life science and biotech companies in the world. With MarketResearch.com’s reliable data-driven insights, you can make informed decisions to guide your business towards success. Choose MarketResearch.com and gain the edge today.
Biologics Industry Research & Market Reports
-
Global Non-Oncology Biopharmaceuticals Market - 2025-2033
... 2025-2033. The global non-oncology biopharmaceuticals market is growing due to the rising demand for advanced biologic therapies for chronic and non-cancerous conditions. Technological advancements in biologics, such as monoclonal antibodies, recombinant proteins, and gene therapies, ... Read More
-
Global Behcets Disease Therapeutics Market 2025-2029
... disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Biological Drugs
... CAGR of 9.1% over the analysis period 2024-2030. Therapeutic Protein, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$289.1 Billion by the end of the analysis ... Read More
-
Biologics
... 8.2% over the analysis period 2024-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis period. ... Read More
-
Biopharmaceutical Logistics
... CAGR of 4.8% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$37.9 Billion by the end of the ... Read More
-
Plasma Protein Therapeutics
... at a CAGR of 4.8% over the analysis period 2024-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$9.3 Billion by the end of the ... Read More
-
Bioburden Testing
... CAGR of 11.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Burn Care
... CAGR of 3.9% over the analysis period 2024-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Ampoules Packaging
... CAGR of 6.2% over the analysis period 2024-2030. Glass, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$5.6 Billion by the end of the analysis period. ... Read More
-
Biologics Safety Testing
... at a CAGR of 11.8% over the analysis period 2024-2030. Residual Host-Cell Proteins & DNA Detection Tests, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$5.8 ... Read More
-
Bioprocess Containers
... CAGR of 23.6% over the analysis period 2024-2030. Upstream Processes, one of the segments analyzed in the report, is expected to record a 26.3% CAGR and reach US$19.6 Billion by the end of the analysis ... Read More
-
Fill Finish Manufacturing
... at a CAGR of 8.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Synthetic Orthobiologics
... CAGR of 5.6% over the analysis period 2024-2030. Osteoarthritis & Degenerative Arthritis, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$456.2 Million by the end of ... Read More
-
Biopharmaceutical Fermentation Systems
... at a CAGR of 4.5% over the analysis period 2024-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by the end of ... Read More
-
Generic Injectables
... CAGR of 11.8% over the analysis period 2024-2030. Large Molecule Injectables, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$145.9 Billion by the end of the ... Read More
-
Autoinjectors
... 15.9% over the analysis period 2024-2030. Disposable Autoinjectors, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$101.1 Billion by the end of the analysis period. Growth ... Read More
-
Orthobiologics
... 4.2% over the analysis period 2024-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in ... Read More
-
Peptide Synthesis
... CAGR of 4.3% over the analysis period 2024-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the analysis period. ... Read More
-
Spine Biologics
... CAGR of 4.4% over the analysis period 2024-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More
-
Virus Filtration Products
... at a CAGR of 12.4% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$7.8 Billion by the end ... Read More
-
Biotechnology Contract Manufacturing Market by Service (Manufacturing, Fill Finish, Packaging), Type (Drug Substance, Drug Product), Scale, Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... period from 2024 to 2033. Key Takeaways: The manufacturing segment held the largest share of the global biotechnology contract manufacturing market in 2023. The biologic drug substance manufacturing segment held the largest share of the ... Read More
-
Biopharmaceutical CMO and CRO Market, By Source (Mammalian and Non-mammalian), By Service (Contract Manufacturing and Contract Research), and By Product (Biologics and Biosimilars), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
... is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis. Market Dynamics: Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand ... Read More
-
Burn Care Centers Market in US 2025-2029
... report on the burn care centers market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Biologic Therapeutic Drugs: Technologies and Global Markets
... The forecast period is 2024 through 2029. The market is segmented based on product type, application, source and region. By product, the market is segmented into monoclonal antibodies, vaccines, peptide hormones, cell and gene therapies ... Read More
-
Global Contract Development and Manufacturing Organization Outsourcing Market 2025-2029
... period. The report on the contract development and manufacturing organization outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More